Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers

NCT03010631 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Cohort 1: Lubiprostone Capsule, Fasted
DRUG: Cohort 1: Lubiprostone Sprinkle Formulation, Fasted
DRUG: Cohort 2: Lubiprostone Sprinkle Formulation, Fed
DRUG: Cohort 2: Lubiprostone Sprinkle Formulation, Fasted

Sponsor

Sucampo Pharma Americas, LLC

Collaborators

[object Object]